Lantheus
LNTH
Collegium Pharmaceutical
COLL
Constellation Brands
STZ
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
US Stock MarketDetailed Quotes
CLAR Clarus
- 4.020
- -0.410-9.26%
Close Mar 10 16:00 ET
- 4.020
- 0.0000.00%
Post 20:01 ET
154.22MMarket Cap-2.93P/E (TTM)
4.420High3.990Low192.45KVolume4.360Open4.430Pre Close784.38KTurnover0.74%Turnover RatioLossP/E (Static)38.36MShares7.43852wk High0.66P/B104.78MFloat Cap3.86852wk Low0.10Dividend TTM26.06MShs Float135.696Historical High2.49%Div YieldTTM9.71%Amplitude2.385Historical Low4.075Avg Price1Lot Size
Clarus Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -7.59%264.32M | -6.66%71.41M | -17.45%67.12M | -2.51%56.48M | -1.38%69.31M | -9.27%286.02M | 366.81%76.5M | -29.74%81.3M | -49.59%57.94M | -37.96%70.28M |
| Operating revenue | -7.59%264.32M | -6.66%71.41M | -17.45%67.12M | -2.51%56.48M | -1.38%69.31M | -9.27%286.02M | 366.81%76.5M | -29.74%81.3M | -49.59%57.94M | -37.96%70.28M |
| Cost of revenue | -8.92%171.7M | -12.55%47.54M | -19.25%43.62M | 2.03%36.08M | -0.69%44.46M | -8.18%188.51M | 582.44%54.36M | -29.19%54.02M | -50.37%35.36M | -35.14%44.77M |
| Gross profit | -5.02%92.62M | 7.78%23.87M | -13.88%23.5M | -9.62%20.41M | -2.58%24.85M | -11.32%97.51M | 227.22%22.14M | -30.79%27.28M | -48.32%22.58M | -42.36%25.51M |
| Operating expense | -0.50%115.79M | -9.28%27.82M | -2.45%28.27M | 4.56%28.48M | 5.88%31.22M | -3.68%116.37M | 62.64%30.67M | -10.38%28.98M | -23.15%27.24M | -13.73%29.48M |
| Selling and administrative expenses | -0.50%115.79M | -9.28%27.82M | -2.45%28.27M | 4.56%28.48M | 5.88%31.22M | -3.68%116.37M | 62.64%30.67M | -10.38%28.98M | -23.15%27.24M | -13.73%29.48M |
| -General and administrative expense | --115.79M | --27.82M | -2.45%28.27M | 4.56%28.48M | 5.88%31.22M | ---- | ---- | --28.98M | --27.24M | --29.48M |
| Operating profit | -22.88%-23.17M | 53.61%-3.95M | -181.17%-4.78M | -73.26%-8.07M | -60.19%-6.37M | -73.61%-18.86M | 76.49%-8.52M | -123.98%-1.7M | -156.57%-4.66M | -139.44%-3.97M |
| Net non-operating interest income expense | 2,089.55%1.47M | 668.57%269K | 1,863.16%373K | 5,587.50%455K | 7,300.00%370K | 67K | -99.31%35K | 100.86%19K | 100.46%8K | 100.45%5K |
| Non-operating interest income | ---- | ---- | 1,863.16%373K | 5,587.50%455K | 7,300.00%370K | ---- | ---- | --19K | --8K | --5K |
| Total other finance cost | -2,089.55%-1.47M | ---269K | ---- | ---- | ---- | ---67K | ---- | ---- | ---- | ---- |
| Other net income (expense) | -3,689.22%-48.88M | -10,897.28%-48.5M | 130.35%583K | 165.98%351K | -182.11%-1.32M | 98.67%-1.29M | 99.51%-441K | 12.68%-1.92M | 70.28%-532K | 178.98%1.6M |
| Special income (charges) | -1,997.20%-47.21M | -2,887.44%-46.16M | 60.64%-581K | 91.69%-63K | -126.70%-408K | 97.65%-2.25M | 98.33%-1.55M | -53.43%-1.48M | -69.57%-758K | 177.80%1.53M |
| -Less：Restructuring and merger&acquisition | 6.57%2.4M | -12.82%1.35M | -60.64%581K | -91.69%63K | 126.70%408K | -32.01%2.25M | 2,591.94%1.55M | 53.43%1.48M | 69.57%758K | -177.80%-1.53M |
| -Less:Impairment of capital assets | --44.81M | --44.81M | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Other non- operating income (expenses) | -274.09%-1.67M | -312.14%-2.34M | 361.57%1.16M | 83.19%414K | -1,296.05%-909K | 192.85%961K | -31.56%1.1M | 64.05%-445K | 116.83%226K | 213.43%76K |
| Income before tax | -251.54%-70.59M | -484.42%-52.18M | -6.11%-3.82M | -40.20%-7.27M | -209.22%-7.31M | 81.32%-20.08M | 92.67%-8.93M | -234.97%-3.6M | -209.83%-5.18M | -134.13%-2.37M |
| Income tax | 516.03%17.85M | 1,343.65%21.14M | 52.40%-664K | -105.92%-1.78M | -154.79%-851K | 70.84%-4.29M | 90.12%-1.7M | -1,580.72%-1.4M | -190.17%-862K | -120.60%-334K |
| Net income | -415.35%-52.29M | -681.03%-65.52M | -149.76%-3.16M | -162.70%-5.49M | 1,269.46%21.88M | 85.46%-10.15M | 89.72%-8.39M | -145.95%-1.26M | -155.55%-2.09M | -69.90%1.6M |
| Net income continuous Operations | -460.15%-88.44M | -914.32%-73.33M | -43.11%-3.16M | -27.09%-5.49M | -218.17%-6.46M | 82.99%-15.79M | 93.09%-7.23M | -180.19%-2.21M | -214.82%-4.32M | -138.26%-2.03M |
| Net income discontinuous operations | 540.73%36.15M | 772.76%7.8M | --0 | --0 | 681.10%28.35M | -75.49%5.64M | ---1.16M | --942K | --2.23M | --3.63M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -415.35%-52.29M | -681.03%-65.52M | -149.76%-3.16M | -162.70%-5.49M | 1,269.46%21.88M | 85.46%-10.15M | 89.72%-8.39M | -145.95%-1.26M | -155.55%-2.09M | -69.90%1.6M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -415.35%-52.29M | -681.03%-65.52M | -149.76%-3.16M | -162.70%-5.49M | 1,269.46%21.88M | 85.46%-10.15M | 89.72%-8.39M | -145.95%-1.26M | -155.55%-2.09M | -69.90%1.6M |
| Basic earnings per share | -407.41%-1.37 | -677.27%-1.71 | -166.67%-0.08 | -133.33%-0.14 | 1,325.00%0.57 | 85.64%-0.27 | 90.00%-0.22 | -142.86%-0.03 | -160.00%-0.06 | -71.43%0.04 |
| Diluted earnings per share | -407.41%-1.37 | -677.27%-1.71 | -166.67%-0.08 | -133.33%-0.14 | 1,325.00%0.57 | 85.64%-0.27 | 90.00%-0.22 | -142.86%-0.03 | -166.67%-0.06 | -69.23%0.04 |
| Dividend per share | 0.00%0.1 | 0.00%0.025 | 0.00%0.025 | 0.00%0.025 | 0.00%0.025 | 0.00%0.1 | 0.00%0.025 | 0.00%0.025 | 0.00%0.025 | 0.00%0.025 |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |